Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
K2 Services Unveils New Corporate Office Location
May 14, 2024 09:37 ET
|
K2 Services
CHICAGO, May 14, 2024 (GLOBE NEWSWIRE) -- K2 Services, a leading provider of comprehensive managed IT services for the legal industry, today announces the relocation of its corporate headquarters...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
May 13, 2024 20:22 ET
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
May 09, 2024 14:51 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
RTI Connext® Named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program
May 09, 2024 10:00 ET
|
Real-Time Innovations (RTI)
RTI Connext® named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program.
Kidney Dialysis Market is expected to reach a revenue of USD 143.8 Bn by 2032, at 6.2% CAGR: Dimension Market Research
May 07, 2024 12:23 ET
|
Dimension Market Research
New York, May 07, 2024 (GLOBE NEWSWIRE) -- Overview The Global Kidney Dialysis Market size reached USD 83.4 billion in 2023 and is further anticipated to reach USD 143.8 billion by 2032 according...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024 07:00 ET
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Retrieve Medical Announces Significant Results from Physician Burnout Study
May 02, 2024 12:58 ET
|
Retrieve Medical, Inc.
Retrieve Medical Announces Significant Results from Physician Burnout Study
British Heart Foundation choose Simpson Associates as a strategic partner to harness the power of Data Science to drive its mission
May 01, 2024 07:48 ET
|
Simpson Associates
Simpson Associates announce a collaboration with the British Heart Foundation (BHF), exploring the power of Data Science for BHF.
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
April 24, 2024 10:18 ET
|
The Hektoen Institute COVID-19 Monument Commission
Global COVID-19 Memorial sculpture, park, & website honoring medical frontline, essential workers, & COVID victims breaking ground this summer in Chicago.